App Reminder on ASA Adherence

Completed · Not applicable

Conditions studied: Thromboembolic Event

In brief

The purpose of this study is to explore the impact of using a smartphone app reminder on medication adherence twice daily in adults prescribed 81 milligrams of aspirin for 35 days as anti-thrombotic therapy after knee or hip arthroplasty. This study will randomly assign participants to get usual postoperative care which is teaching with verbal instructions and printed information about taking the aspirin at the time of discharge, or to have an app on your smartphone with preset reminders in addition to usual postoperative discharge teaching after surgery.

Key facts

Study ID

NCT03244267

Run by

Emory University

People needed

195

Starts

2017-10-03

Expected to finish

2019-03-08

Last updated by the study team

2019-10-23

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prescribed aspirin 81 mg twice a day for 35 days
• Ability to write and speak English
• Have a smart phone with the capacity to download and set an app
• Own and use a smart phone for communication purposes

You may not qualify if…

• Diagnosis of mental illness
• Do not own a smart phone

Where it is running

• Emory Orthopedic and Spine Hospital — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.